Search Within

Shanu Modi

  1. "Survivorship Research"
Formats
  1. Meeting Abstract (64)
  2. Journal Article (49)
Groups
  1. Breast Medicine Service (113)
  2. Department of Medicine (113)
  3. Solid Tumor Oncology Division (113)
  4. Survivorship Research (113)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (71)
  6. Epidemiology and Biostatistics (70)

More Groups

People
  1. Clifford Hudis (79)
  2. Larry Norton (50)
  3. Sujata Patil (43)
  4. Chau Dang (41)
  5. Sarat Chandarlapaty (36)
  6. Diana Lake (33)

More People

Years
  1. 2024 (7)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (3)
  5. 2020 (7)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Cancer Research (23)
  3. Breast Cancer Research and Treatment (11)
  4. Clinical Breast Cancer (7)
  5. Clinical Cancer Research (7)
  6. Annals of Oncology (5)

More Publications

Publishers
  1. American Association for Cancer Research (32)
  2. American Society of Clinical Oncology (32)
  3. Springer (11)
  4. Elsevier Inc. (9)
  5. Oxford University Press (8)
  6. American Medical Association (6)

More Publishers

Results (113)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary safety results of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2 overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C. T.; Lin, N. U.; Lake, D.; Dickler, M. N.; Modi, S.; Seidman, A. D.; Steingart, R. M.; Norton, L.; Winer, E. P.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Tanespimycin (17-allylamino-17-demethoxy-geldanamycin; 17-AAG) in breast cancer
    Meeting Abstract

    Modi, S.; Sugarman, S.; Stopeck, A.; Linden, H.; Ma, W.; Chandarlapaty, S.; Solit, D.; Norton, L.; Rosen, N.; Kersey, K.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Genetically guided choices for chemotherapy - Reply
    Journal Article

    Hudis, C. A.; Modi, S.
    JAMA - Journal of the American Medical Association (2008)

    Fulltext@MSK | Save
  • In reply
    Journal Article

    Hudis, C. A.; Modi, S.
    JAMA - Journal of the American Medical Association (2008)

    Fulltext@MSK | Save
  • The heat shock protein 90 chaperone complex: An evolving therapeutic target
    Journal Article

    Barginear, M. F.; Van Poznak, C.; Rosen, N.; Modi, S.; Hudis, C. A.; Budman, D. R.
    Current Cancer Drug Targets (2008)

    Fulltext@MSK | Save
  • Phase I trial of alvespimycin (KOS-1022; 17-DMAG) and trastuzumab (T)
    Meeting Abstract

    Miller, K.; Rosen, L. S.; Modi, S.; Schneider, B.; Roy, J.; Chap, L.; Paulsen, M.; Kersey, K.; Hannah, A.; Hudis, C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Tanespimycin (an Hsp90 inhibitor) and trastuzumab is an active combination in patients (pts) with Her2-positive trastuzumab-refractory metastatic breast cancer (MBC): Phase 2 trial
    Meeting Abstract

    Modi, S.; Stopeck, A.; Kinden, H.; Sugarman, S.; Ma, W.; Solit, D.; Kersey, K.; Johnson, R.; Hannah, A. L.; Hudis, C.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I dose-escalation study
    Journal Article

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Mendelson, D.; Solit, D. B.; Bagatell, R.; Ma, W.; Wheler, J.; Rosen, N.; Norton, L.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Preoperative chemotherapy for breast cancer: Miracle or mirage?
    Journal Article

    Hudis, C.; Modi, S.
    JAMA - Journal of the American Medical Association (2007)

    Fulltext@MSK | Save
  • Phase I dose escalating trial of KOS-953 (heat shock protein 90 inhibitor) and trastuzumab (T)
    Meeting Abstract

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Solit, D.; Bagatell, R.; Ma, W.; Wheler, J.; Cropp, G. F.; Rosen, N.; Johnson, R. G. Jr; more...
    Cancer Research (2006)

    Fulltext@MSK | Save